A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update.

Imbalances in gut microbiota are associated with metabolic disorder, which are a group of obesity-related metabolic abnormalities that increase an individual's risk of developing type 2 diabetes (T2D) and Alzheimer's disease (AD). Although a number of risk factors have been postulated that may trigger the development of AD, the root cause of this disease is still a matter of debate. This review further investigates the etiology of AD by accumulating the current role played by gut microbiota in human, and trying to establish an inter-link between T2D and AD pathogenesis. There is a growing body of evidence which suggests that obesity is associated with alteration in the normal gut flora, reduced bacterial diversity, metabolic pathways and altered representation of bacterial genes. Obesity and T2D are considered to be induced as a result of changes within the composition of gut microbiota. The evidence gathered so far clearly advocates the involvement of gut microbes in causing obesity, a state of chronic and low-grade inflammation. Hence, understanding the microbiota of the gut is significant in relation to inflammation, as it is a key contributor for diabetes which has a direct relation to the AD pathogenesis. Comparative analysis of gut microbiota may enable further novel insight into the complex biology of AD, which is very important in order to take preventive measure such as early diagnosis, identification of new therapeutic targets and development of novel drugs.

[1]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[2]  W. Moore,et al.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians. , 1974, Applied microbiology.

[3]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[4]  E. Murphy,et al.  Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models , 2010, Gut.

[5]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[6]  R. Strieter,et al.  CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. , 2009, Cell metabolism.

[7]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[8]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[9]  Ruslan Medzhitov,et al.  Toll-Like Receptor Signaling Pathways , 2003, Science.

[10]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.

[11]  Bernard Henrissat,et al.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla , 2009, Proceedings of the National Academy of Sciences.

[12]  Caballero Ae.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. , 2004 .

[13]  F. Hu,et al.  A Marker of Endotoxemia Is Associated With Obesity and Related Metabolic Disorders in Apparently Healthy Chinese , 2010, Diabetes Care.

[14]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Kashyap,et al.  Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. , 2011, Metabolic syndrome and related disorders.

[16]  J. Doré,et al.  Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.

[17]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[18]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[19]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[20]  A M Stephen,et al.  The microbial contribution to human faecal mass. , 1980, Journal of medical microbiology.

[21]  S. Devaraj,et al.  Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome , 2012, Diabetes Care.

[22]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[23]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[24]  D. Savage.  Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.

[25]  Cynthia L Sears,et al.  A dynamic partnership: celebrating our gut flora. , 2005, Anaerobe.

[26]  Roy Taylor,et al.  Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause , 2008, Diabetologia.

[27]  Fabrice Armougom,et al.  Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients , 2009, PloS one.

[28]  P. Halban,et al.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. , 2008, The Journal of clinical endocrinology and metabolism.

[29]  H. Tilg,et al.  Obesity and the microbiota. , 2009, Gastroenterology.

[30]  F. Shanahan.  The host-microbe interface within the gut. , 2002, Best practice & research. Clinical gastroenterology.

[31]  P. Brun,et al.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[32]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[33]  S. M. de la Monte,et al.  Insulin resistance and Alzheimer's disease. , 2009, BMB reports.

[34]  J. Ruidavets,et al.  Energy intake is associated with endotoxemia in apparently healthy men. , 2008, The American journal of clinical nutrition.

[35]  J. Gordon,et al.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[37]  Shuzhong Guo,et al.  The role of bifidobacteria in gut barrier function after thermal injury in rats. , 2006, The Journal of trauma.

[38]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[39]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[40]  R. Alfenas,et al.  The influence of endotoxemia on the molecular mechanisms of insulin resistance , 2012 .

[41]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[42]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[43]  Ying Xiao,et al.  Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. , 2007, Nutrition.

[44]  M. Blaut,et al.  Absence of intestinal microbiota does not protect mice from diet-induced obesity , 2010, British Journal of Nutrition.

[45]  K. Julge,et al.  Allergy development and the intestinal microflora during the first year of life. , 2001, The Journal of allergy and clinical immunology.

[46]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[47]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  H. Barakat,et al.  Ketone body metabolism in lean and obese women. , 2005, Metabolism: clinical and experimental.

[49]  C. Dinarello,et al.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.

[50]  P. Greengard,et al.  Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.

[51]  A. Schmidt,et al.  The RAGE axis in early diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[52]  H. Ellingsgaard,et al.  Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction , 2009, Archives of physiology and biochemistry.

[53]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[54]  A. Cerami,et al.  Protein glycation, diabetes, and aging. , 2001, Recent progress in hormone research.

[55]  T. Montine,et al.  Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. , 2005, Archives of neurology.

[56]  L. Duffy,et al.  In Vivo Effects of Bifidobacteria and Lactoferrin on Gut Endotoxin Concentration and Mucosal Immunity in Balb/c Mice , 2004, Digestive Diseases and Sciences.

[57]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[58]  G. Gibson.  Fibre and effects on probiotics (the prebiotic concept) , 2004 .

[59]  T. Montine,et al.  Cerebrospinal Fluid Aβ42, Tau, and F2-Isoprostane Concentrations in Patients With Alzheimer Disease, Other Dementias, and in Age-Matched Controls , 2001 .

[60]  A. Martí,et al.  Interplay Between Weight Loss and Gut Microbiota Composition in Overweight Adolescents , 2009, Obesity.

[61]  R. Curi,et al.  Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. , 2009, Clinical science.

[62]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. B. Kim,et al.  Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. , 2006, Biochemical and biophysical research communications.

[64]  L. Beaugerie,et al.  Antibiotic-associated diarrhoea , 2004 .

[65]  S. Devaraj,et al.  Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects , 2010, Diabetes Care.

[66]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[67]  U. Steinhoff.  Who controls the crowd? New findings and old questions about the intestinal microflora. , 2005, Immunology letters.

[68]  Eleazar Eskin,et al.  Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. , 2013, Cell metabolism.

[69]  A. Testro,et al.  Toll‐like receptors and their role in gastrointestinal disease , 2009, Journal of gastroenterology and hepatology.

[70]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[71]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[72]  J. Tanti,et al.  C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet , 2007, Diabetologia.

[73]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[74]  Suzanne Craft,et al.  Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation , 2005, Neurobiology of Aging.

[75]  Junwei Yang,et al.  Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells. , 2011, Biochemical and biophysical research communications.

[76]  R. Nagaraj,et al.  Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes. , 1999, Archives of biochemistry and biophysics.

[77]  H. Flint,et al.  Human colonic microbiota associated with diet, obesity and weight loss , 2008, International Journal of Obesity.

[78]  M. Banerjee,et al.  The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. , 2011, Molecular genetics and metabolism.

[79]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[80]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.